Skip to main content
Erschienen in: World Journal of Urology 1/2013

01.02.2013 | Topic Paper

The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database

verfasst von: Laurent Nison, Morgan Rouprêt, Grégory Bozzini, Adil Ouzzane, François Audenet, Géraldine Pignot, Alain Ruffion, Jean-Nicolas Cornu, Sophie Hurel, Antoine Valeri, Mathieu Roumiguie, Thomas Polguer, Nicolas Hoarau, Olivier Mérigot de Treigny, Evanguelos Xylinas, Alexandre Matte, Stéphane Droupy, Pierre Olivier Fais, Aurélien Descazeaud, Pierre Colin, MD for the French Collaborative National Database on UUT-UC

Erschienen in: World Journal of Urology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

According to the current upper urinary tract urothelial carcinomas (UTUC) guidelines, ureteroscopic evaluation (URS) is recommended to improve diagnostic accuracy and obtain a grade (by biopsy or cytology). However, URS may delay radical surgery [e.g., nephroureterectomy (RNU)]. The objective of this study was to evaluate the influence of URS implementation before RNU on patient survival.

Methods

A French multicentre retrospective study including 512 patients with nonmetastatic UTUC was conducted between 1995 and 2011. Achievement of ureteroscopy (URS), treatment time (time between imaging diagnosis and RNU), tumour location, pT–pN stage, grade, lymphovascular invasion (LVI) and the presence of invaded surgical margins (R+) were evaluated as prognostic factors for survival using univariate and multivariate Cox regression analyses. Cancer-specific survival (CSS), recurrence-free survival (RFS) and metastasis-free survival (MFS) were calculated using the Kaplan–Meier method.

Results

A total of 170 patients underwent ureteroscopy prior to RNU (URS+ group), and 342 did not undergo URS (URS−). The median treatment time was significantly longer in the URS+ group (79.5 vs. 44.5 days, p = 0.04). Ureteroscopic evaluation was correlated with ureteral location and lower stage and tumour grade (p = 0.022, 0.005, 0.03, respectively). Tumour stage, LVI+ and R+ status were independently associated with CSS (p = 0.024, 0.049 and 0.006, respectively). The 5-year CSS, RFS and MFS did not differ between the two groups (p = 0.23, 0.89 and 0.35, respectively). These results were confirmed for muscle-invasive (MI) UTUC (p = 0.21, 0.44 and 0.67 for CSS, RFS and MFS, respectively).

Conclusions

Despite the increased time to radical surgery, diagnostic ureteroscopy can be systematically performed for the appraisal of UTUC to refine the therapeutic strategy without significantly affecting oncological outcomes, even for MI lesions.
Literatur
1.
Zurück zum Zitat Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164:1523–1525PubMedCrossRef Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164:1523–1525PubMedCrossRef
2.
Zurück zum Zitat Rouprêt M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, Babjuk M, Oosterlinck W (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59:584–594PubMedCrossRef Rouprêt M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, Babjuk M, Oosterlinck W (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59:584–594PubMedCrossRef
3.
Zurück zum Zitat Pak RW, Moskowitz EJ, Bagley DH (2009) What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival. J Endourol 23:341–346PubMedCrossRef Pak RW, Moskowitz EJ, Bagley DH (2009) What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival. J Endourol 23:341–346PubMedCrossRef
4.
Zurück zum Zitat Takao A, Saika T, Uehara S, Monden K, Abarzua F, Nasu Y, Kumon H (2010) Indications for ureteropyeloscopy based on radiographic findings and urine cytology in detection of upper urinary tract carcinoma. Jpn J Clin Oncol 40:1087–1091PubMedCrossRef Takao A, Saika T, Uehara S, Monden K, Abarzua F, Nasu Y, Kumon H (2010) Indications for ureteropyeloscopy based on radiographic findings and urine cytology in detection of upper urinary tract carcinoma. Jpn J Clin Oncol 40:1087–1091PubMedCrossRef
5.
Zurück zum Zitat Audenet F, Traxer O, Yates DR, Cussenot O, Rouprêt M (2012) Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract. BJU Int 109:608–613; discussion 613–614PubMedCrossRef Audenet F, Traxer O, Yates DR, Cussenot O, Rouprêt M (2012) Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract. BJU Int 109:608–613; discussion 613–614PubMedCrossRef
6.
Zurück zum Zitat Brown GA, Matin SF, Busby JE, Dinney CPN, Grossman HB, Pettaway CA, Munsell MF, Kamat AM (2007) Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology 70:252–256PubMedCrossRef Brown GA, Matin SF, Busby JE, Dinney CPN, Grossman HB, Pettaway CA, Munsell MF, Kamat AM (2007) Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology 70:252–256PubMedCrossRef
7.
Zurück zum Zitat Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD (2010) Pre-operative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184:69–73PubMedCrossRef Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD (2010) Pre-operative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184:69–73PubMedCrossRef
8.
Zurück zum Zitat Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, Shariat SF, Wood CG, Zigeuner R (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62:100–114PubMedCrossRef Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, Shariat SF, Wood CG, Zigeuner R (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62:100–114PubMedCrossRef
9.
Zurück zum Zitat Fahmy NM, Mahmud S, Aprikian AG (2006) Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature. Eur Urol 50:1176–1182PubMedCrossRef Fahmy NM, Mahmud S, Aprikian AG (2006) Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature. Eur Urol 50:1176–1182PubMedCrossRef
10.
Zurück zum Zitat Keeley FX, Kulp DA, Bibbo M, McCue PA, Bagley DH (1997) Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 157:33–37PubMedCrossRef Keeley FX, Kulp DA, Bibbo M, McCue PA, Bagley DH (1997) Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 157:33–37PubMedCrossRef
11.
Zurück zum Zitat Razavi SA, Sadigh G, Kelly AM, Cronin P (2012) Comparative effectiveness of imaging modalities for the diagnosis of upper and lower urinary tract malignancy: a critically appraised topic. Acad Radiol [Epub ahead of print] Razavi SA, Sadigh G, Kelly AM, Cronin P (2012) Comparative effectiveness of imaging modalities for the diagnosis of upper and lower urinary tract malignancy: a critically appraised topic. Acad Radiol [Epub ahead of print]
12.
Zurück zum Zitat Messer J, Shariat SF, Brien JC, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Steinberg G, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD (2011) Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int 108:701–705PubMed Messer J, Shariat SF, Brien JC, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Steinberg G, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD (2011) Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int 108:701–705PubMed
13.
Zurück zum Zitat Clements T, Messer JC, Terrell JD, Herman MP, Ng CK, Scherr DS, Scoll B, Boorjian SA, Uzzo RG, Wille M, Eggener SE, Lucas SM, Lotan Y, Shariat SF, Raman JD (2012) High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol 26:398–402PubMedCrossRef Clements T, Messer JC, Terrell JD, Herman MP, Ng CK, Scherr DS, Scoll B, Boorjian SA, Uzzo RG, Wille M, Eggener SE, Lucas SM, Lotan Y, Shariat SF, Raman JD (2012) High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol 26:398–402PubMedCrossRef
14.
Zurück zum Zitat Hendin BN, Streem SB, Levin HS, Klein EA, Novick AC (1999) Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma. J Urol 161:783–785PubMedCrossRef Hendin BN, Streem SB, Levin HS, Klein EA, Novick AC (1999) Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma. J Urol 161:783–785PubMedCrossRef
15.
Zurück zum Zitat Holmäng S, Johansson SL (2006) Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer. Scand J Urol Nephrol 40:479–484PubMedCrossRef Holmäng S, Johansson SL (2006) Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer. Scand J Urol Nephrol 40:479–484PubMedCrossRef
16.
Zurück zum Zitat Ishikawa S, Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S, Kubota K, Matsuno Y, Osawa T, Shinno Y, Kumagai A, Togashi M, Matsuda H, Mori T, Nonomura K (2010) Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol 184:883–887PubMedCrossRef Ishikawa S, Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S, Kubota K, Matsuno Y, Osawa T, Shinno Y, Kumagai A, Togashi M, Matsuda H, Mori T, Nonomura K (2010) Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol 184:883–887PubMedCrossRef
17.
Zurück zum Zitat Boorjian S, Ng C, Munver R, Palese MA, Vaughan ED Jr, Sosa RE, Del Pizzo JJ, Scherr DS (2005) Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma. Urology 66:283–287PubMedCrossRef Boorjian S, Ng C, Munver R, Palese MA, Vaughan ED Jr, Sosa RE, Del Pizzo JJ, Scherr DS (2005) Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma. Urology 66:283–287PubMedCrossRef
18.
Zurück zum Zitat Favaretto RL, Shariat SF, Savage C, Godoy G, Chade DC, Kaag M, Bochner BH, Coleman J, Dalbagni G (2012) Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 109:77–82PubMedCrossRef Favaretto RL, Shariat SF, Savage C, Godoy G, Chade DC, Kaag M, Bochner BH, Coleman J, Dalbagni G (2012) Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 109:77–82PubMedCrossRef
19.
Zurück zum Zitat Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ (2010) Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. Urology 75:328–332PubMedCrossRef Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ (2010) Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. Urology 75:328–332PubMedCrossRef
20.
Zurück zum Zitat Colin P, Ouzzane A, Yates DR, François A, Pignot G, Arvin-Berod A, de Treigny OM, Laurent G, Valeri A, Jacques I, Saint F, Gardic S, Gres P, Rozet F, Neuzillet Y, Ruffion A, Rouprêt M (2012) Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival. Ann Surg Oncol [Epub ahead of print] Colin P, Ouzzane A, Yates DR, François A, Pignot G, Arvin-Berod A, de Treigny OM, Laurent G, Valeri A, Jacques I, Saint F, Gardic S, Gres P, Rozet F, Neuzillet Y, Ruffion A, Rouprêt M (2012) Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival. Ann Surg Oncol [Epub ahead of print]
21.
Zurück zum Zitat Waldert M, Karakiewicz PI, Raman JD, Remzi M, Isbarn H, Lotan Y, Capitanio U, Bensalah K, Marberger MJ, Shariat SF (2010) A delay in radical nephroureterectomy can lead to upstaging. BJU Int 105:812–817PubMedCrossRef Waldert M, Karakiewicz PI, Raman JD, Remzi M, Isbarn H, Lotan Y, Capitanio U, Bensalah K, Marberger MJ, Shariat SF (2010) A delay in radical nephroureterectomy can lead to upstaging. BJU Int 105:812–817PubMedCrossRef
22.
Zurück zum Zitat Sundi D, Svatek RS, Margulis V, Wood CG, Matin SF, Dinney CP, Kamat AM (2012) Upper tract urothelial carcinoma: impact of time to surgery. Urol Oncol 30:266–272PubMedCrossRef Sundi D, Svatek RS, Margulis V, Wood CG, Matin SF, Dinney CP, Kamat AM (2012) Upper tract urothelial carcinoma: impact of time to surgery. Urol Oncol 30:266–272PubMedCrossRef
23.
Zurück zum Zitat Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS Jr (2012) Long-term outcomes of immediate versus delayed nephroureterectomy for upper tract urothelial carcinoma. J Endourol 26:566–573PubMedCrossRef Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS Jr (2012) Long-term outcomes of immediate versus delayed nephroureterectomy for upper tract urothelial carcinoma. J Endourol 26:566–573PubMedCrossRef
24.
Zurück zum Zitat Grasso M, McCue P, Bagley DH (1992) Multiple urothelial recurrences of renal cell carcinoma after initial diagnostic ureteroscopy. J Urol 147:1358–1360PubMed Grasso M, McCue P, Bagley DH (1992) Multiple urothelial recurrences of renal cell carcinoma after initial diagnostic ureteroscopy. J Urol 147:1358–1360PubMed
25.
Zurück zum Zitat Lim DJ, Shattuck MC, Cook WA (1993) Pyelovenous lymphatic migration of transitional cell carcinoma following flexible ureterorenoscopy. J Urol 149:109–111PubMed Lim DJ, Shattuck MC, Cook WA (1993) Pyelovenous lymphatic migration of transitional cell carcinoma following flexible ureterorenoscopy. J Urol 149:109–111PubMed
26.
Zurück zum Zitat Kulp DA, Bagley DH (1994) Does flexible ureteropyeloscopy promote local recurrence of transitional cell carcinoma? J Endourol 8:111–113PubMedCrossRef Kulp DA, Bagley DH (1994) Does flexible ureteropyeloscopy promote local recurrence of transitional cell carcinoma? J Endourol 8:111–113PubMedCrossRef
27.
Zurück zum Zitat Azémar M-D, Comperat E, Richard F, Cussenot O, Rouprêt M (2011) Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 29:130–136PubMedCrossRef Azémar M-D, Comperat E, Richard F, Cussenot O, Rouprêt M (2011) Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 29:130–136PubMedCrossRef
28.
Zurück zum Zitat Pfister C, Roupret M, Wallerand H, Davin J-L, Quintens H, Guy L, Houede N, Bernardini S, Larré S, Mazerolles C, Roy C, Amsellem D, Saint F, Irani J, Soulié M (2010) Recommendations onco–urology 2010: urothelial tumors. Prog Urol 20(Suppl 4):S255–S274PubMedCrossRef Pfister C, Roupret M, Wallerand H, Davin J-L, Quintens H, Guy L, Houede N, Bernardini S, Larré S, Mazerolles C, Roy C, Amsellem D, Saint F, Irani J, Soulié M (2010) Recommendations onco–urology 2010: urothelial tumors. Prog Urol 20(Suppl 4):S255–S274PubMedCrossRef
29.
Zurück zum Zitat Irani J, Bernardini S, Bonnal J-L, Chauvet B, Colombel M, Davin J-L, Laurent G, Lebret T, Maidenberg M, Mazerolles C, Pfister C, Roupret M, Roy C, Rozet F, Saint F, Theodore C (2007) Urothelial tumors. Prog Urol 17:1065–1098PubMedCrossRef Irani J, Bernardini S, Bonnal J-L, Chauvet B, Colombel M, Davin J-L, Laurent G, Lebret T, Maidenberg M, Mazerolles C, Pfister C, Roupret M, Roy C, Rozet F, Saint F, Theodore C (2007) Urothelial tumors. Prog Urol 17:1065–1098PubMedCrossRef
Metadaten
Titel
The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database
verfasst von
Laurent Nison
Morgan Rouprêt
Grégory Bozzini
Adil Ouzzane
François Audenet
Géraldine Pignot
Alain Ruffion
Jean-Nicolas Cornu
Sophie Hurel
Antoine Valeri
Mathieu Roumiguie
Thomas Polguer
Nicolas Hoarau
Olivier Mérigot de Treigny
Evanguelos Xylinas
Alexandre Matte
Stéphane Droupy
Pierre Olivier Fais
Aurélien Descazeaud
Pierre Colin
MD for the French Collaborative National Database on UUT-UC
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 1/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-012-0959-1

Weitere Artikel der Ausgabe 1/2013

World Journal of Urology 1/2013 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.